BRIEF: Baiyunshan invests $105 million for 11% of NanJing Pharma
Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. (0874.HK; 600332.SH) said on Sunday it paid 749 million yuan ($105 million) via its Guangzhou GP Fund II subsidiary for 11.04% of NanJing Pharmaceutical…
Baiyunshan serves up high dividend in lieu of vanilla results
Profits from the company’s Great Health segment rose 14% in the first half of 2025, primarily driven by strong results for its popular Wanglaoji herbal tea Key Takeaways: Baiyunshan’s revenue…
Recent Articles
BRIEF: Baiyunshan invests $105 million for 11% of NanJing Pharma
0874.HK
600332.SHG
600713.SHG
Baiyunshan serves up high dividend in lieu of vanilla results
0874.HK
600332.SHG
RELATED ARTICLES
-
Baiyunshan serves up high dividend in lieu of vanilla results
0874.HK 600332.SHG
-
BRIEF: Green Economy invests $1.48 million in Bayed Health Group IPO
1315.HK 2609.HK
-
BRIEF: Yunfeng invests $44 million for 10,000 ether tokens
0376.HK
-
WuXi group wrestles with uncertainty over pharma tariffs
2268.HK
-
CSPC Pharma teases big bucks deals after earnings miss
1093.HK
- BRIEF: Innogen launches $87 million Hong Kong IPO
- Will Trump’s drug order put the brakes on China’s overseas pharma drive?
